New technology could predict the risk of type 2 diabetes
Researchers have announced a new technology-based approach that could lead to a more accurate identification of type 2 diabetes...
List view / Grid view
Biomarkers are a naturally occurring molecule, gene, or characteristic by which a particular disease can be identified.
Researchers have announced a new technology-based approach that could lead to a more accurate identification of type 2 diabetes...
New technology being developed by researchers is using artificial intelligence to help detect melanoma skin cancer earlier...
Researchers have discovered a new biomarker associated with a rare metabolic disorder may facilitate better diagnosis and identification of new drugs...
Scientists at the University of Copenhagen have identified a unique cell surface protein present on human pancreatic precursor cells providing for the first time a molecular handle to purify the cells whose fate is to become cells of the pancreas - including insulin producing cells.
Canadian researchers have identified several unknown chemicals that were consistently associated with babies who had cystic fibrosis (CF), including two different drug and environmental compounds the infants secreted in sweat at much lower concentration levels...
Physical biomarkers have been discovered that may help diagnose the changes to proteins found in the spinal fluid and blood of Alzheimer's patients...
A newly identified biomarker panel could pave the way to earlier detection and better treatment for pancreatic cancer, according to new research...
Rheumatoid arthritis (RA) is joint-related, immune-based inflammatory disarray that affects almost 1% of the world’s population. The most evidenced pathogenesis is T-cell activation, which leads to clusters of differentiation (CD) in the T-cells and concurrently increases various inflammatory biomarkers.
Researchers at the University of Birmingham have identified inflammatory biomarkers which indicate whether the brain has suffered injury.
A review of Keap1/Nrf2 modulation of ROS homeostasis, and its pivotal role in the pathogenesis of cancer, Type 2 diabetes mellitus & neurological disorders.
Included in this Screening In-Depth Focus: Phenotypic and target-based screening; Killing cancer cells using clinical drug resistance; Inflammatory biomarkers as a herbal anti-arthritic drug discovery tool...
Since the sequence of the human genome was published some 20 years ago, omics strategies have enabled the generation of detailed molecular signatures of cancers and their subtypes.
Included in this issue: Technology convergence improves testing; Screening; Stem Cells; Targets; Mass Spectrometry; and Therapeutics in Alzheimer's disease...
Measuring a blood marker, copeptin, can successfully predict the risk of heart attacks in people with type-2 diabetes.
Study shows 'liquid biopsy' after abnormal mammogram and other imaging can help rule out breast cancer, reduce breast biopsy by up to 67% in women...